| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4749764
Max Phase: Preclinical
Molecular Formula: C19H18BrN3O4S
Molecular Weight: 464.34
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C(C)=O)C4)cc(Br)c1OC
Standard InChI: InChI=1S/C19H18BrN3O4S/c1-9(24)23-5-4-11-14(8-23)28-19-15(11)18(25)21-17(22-19)10-6-12(20)16(27-3)13(7-10)26-2/h6-7H,4-5,8H2,1-3H3,(H,21,22,25)
Standard InChI Key: QWPDPTUHQLEUJP-UHFFFAOYSA-N
Associated Targets(Human)
KB-V1 202 Activities
HCT-116 91556 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
518A2 464 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
EA.hy 926 491 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 464.34 | Molecular Weight (Monoisotopic): 463.0201 | AlogP: 3.34 | #Rotatable Bonds: 3 |
| Polar Surface Area: 84.52 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.03 | CX Basic pKa: 0.54 | CX LogP: 2.37 | CX LogD: 2.29 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.64 | Np Likeness Score: -1.32 |
References
| 1. Gold M,Köhler L,Lanzloth C,Andronache I,Anant S,Dandawate P,Biersack B,Schobert R. (2020) Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones., 189 [PMID:31958738] [10.1016/j.ejmech.2020.112060] |
Source
Source(1):